Bart Becht Chief Executive

Total Page:16

File Type:pdf, Size:1020Kb

Bart Becht Chief Executive Shareholders’ Review and Summary Financial Statement 2007 Seeing is believing Over 15 million products sold every day! Leading the way Our Power Brands go from strength to strength Delivering the goods Our 8th consecutive year of above industry average growth Visible gains Dividend up by 21% Chief Executive’s review Seeing is believing Our results speak for themselves. They articulate just how much we live and love what we do. And that’s the driving force behind the strength of our brands and our success We believe at the heart of our success lies our clear consumer-centric vision, a clear and consistent strategy, the strength of our organisation and culture and our ever stronger product portfolio of globally leading brands in attractive categories. Bart Becht Chief Executive Our vision is to deliver consumers and customers better • Support these brands with a marketing investment that solutions for that short period of time every day that they use is amongst the highest in the industry. household cleaning, health or personal care products. Our • Continue to roll out our Power Brands into new enduring passion to make continuous progress in this area geographies to make them stronger market leaders and forms the foundation of our success. further enhance our corporate net revenue growth. A clear and consistent strategy Transforming growth into profit and cash flow Disproportionate focus on our 18 Power Brands to realise We focus on turning the growth of the business into our vision and drive above industry growth attractive profit and cash flow through margin expansion • We narrowly focus on these 18 brands as they typically and cash conversion. are global market leaders in categories with strong • We expand margins through an unrelenting attention growth potential. to cost optimisation and by focusing on higher margin • We use high levels of brand investment and innovation products and categories. to nurture our Power Brands to above industry and • We focus on converting this to cash through tight company average growth rates. control and management of our net working capital • Continuously develop innovative new products to and relentless attention to cash. strengthen the position of the Power Brands in their categories and enhance their consumer appeal. 2007 was a great year! relief provide clear opportunities for further growth for the Group financial highlights brand in the USA and in new geographies. We made excellent progress in making our 18 Power Brands 2007 2006 change stronger global market leaders. Bar one, that held flat, all As we are looking forward, we are excited by the growth and £m £m % Power Brands gained market share due to high levels of brand margin potential the Power Brands in consumer healthcare can Net revenues 5,269 4,922 +7 investment and the launch of exciting new products like Operating profit 1,233 910 +35 bring to Reckitt Benckiser. Air Wick Freshmatic Mini and Vanish Oxi Action Multi. Not only Adjusted operating profit* 1,190 1,059 +12 Strong in-market results drove our financial success in the Net income for the year 938 674 +39 did the Power Brands gain in the markets where they are sold, year. 2007 was the eighth consecutive year of above industry Adjusted net income for the year* 905 786 +15 they are increasingly becoming global leaders as we roll these average net revenue and profit growth for Reckitt Benckiser. Diluted earnings per share 127.9p 91.8p +39 brands out to new markets. Adjusted diluted earnings per share* 123.4p 107.1p +15 Net revenues at constant exchange grew by 10% in total and Power Brands now account for 61% of Reckitt Benckiser’s Declared dividend per share 55.0p 45.5p +21 9% on a like-for-like basis, with exchange reducing both total net revenues, up from 40% in 2001. The continued numbers by 3%. Adjusted profit for the year advanced by 15% *adjusted to exclude the impact of exceptional items strong development behind these increasingly clear global at actual exchange. leaders in categories with strong growth potential positions the Company well for the future. The strong financial results and confidence in the continued momentum of the Company led the Board to increase 2007 We also started to realise our ambition of becoming a real dividends by 21% and continue with a £300m share buy global player in consumer healthcare, another area where back programme. we believe the Company can achieve good growth at very attractive margins. Investors often ask us why we have been successful and even more importantly if we can continue our track record. Since In February 2006, we acquired the Boots Healthcare the formation of Reckitt Benckiser in 1999, the Company has International (BHI) business. In 2007, not only did we complete delivered consistently above industry average growth in net the integration of BHI, delivering more than the originally revenues and profits. We believe at the heart of our success lies targeted synergies and one year ahead of schedule, we our consumer-centric vision, a clear and consistent strategy, the managed to grow the BHI business by 10% on a true like-for- strength of our organisation and culture and our ever stronger like basis, well ahead of ingoing assumptions. Most of this product portfolio of globally leading brands in attractive Seeing is believing growth was driven by the three new Power Brands that came Over 15 million products sold every day! categories. We believe the same elements position us well for with the BHI acquisition: Nurofen, Strepsils and Clearasil. future success. Leading the way Our Power Brands go from strength to strength Delivering the goods Our 8 consecutive year of above industry average growth Towards the end of 2007, we announced our intent to acquire Visible gains Dividend up by 21% Adams Respiratory Therapeutics, Inc., a transaction which A consumer-centric vision completed on 30 January 2008. Adams allows us to enter the Our vision is to deliver consumers and customers better USA, the largest consumer healthcare market in the world solutions for that short period of time every day that they use with Mucinex, the clear No.1 in the US Cough Relief market. household cleaning, health or personal care products. Our Mucinex will become our 19th Power Brand. Its unique and enduring passion to make continuous progress in this area patent-protected formulas and consumer claims of 12-hour forms the foundation of our success. Seeing is believing There’s no hiding in this business. Our products are judged millions of times a day. When people open the dishwasher door, they’re looking for perfection. When they see it, they can believe it, because Finish, like everything else we do, delivers every time. 2 Reckitt Benckiser Shareholders’ Review 2007 A clear and consistent strategy and the excitement of taking calculated risks in the search for Net revenues £m better solutions. Not for us a culture of consensus, rather we 6000 6000 Disproportionate focus on our 18 Power Brands to realise enjoy constructive conflict if it leads to better decision-making. 5000 our vision and drive above industry average growth 5,269 5000 Ours is a culture that works for us. That is why we work 4,922 4000 We narrowly focus on these 18 brands as they typically very hard on recruiting and developing our talent to fit with 4,179 4000 3,713 3,871 our culture. 3000 are global market leaders in categories with strong growth 3000 potential. These are the brands that receive the lion’s share of new products to realise our vision and the bulk of our media Delivering shareholder value 2000 2000 and marketing investment to consistently grow them ahead of 1000 …in the short-term 1000 the market and company average. The result of our vision, strategy and values brought to life 0 0 Our Power Brands now account for 61% of our total business 03 04 05 06 07 by our passionate people is a performance that has delivered – up from 40% in 2001. Many of them are world leaders like growing profit and cash flow for shareholders. Our growth has Vanish in Fabric Treatment, Finish and Calgonit in Automatic outpaced our industry consistently over the past eight years. Operating margins (adjusted) % Gross margin % +160bps 60 Dishwashing or Lysol and Dettol in Disinfection. 25 And shareholders have been rewarded for this with consistent 25 60 We use high levels of brand investment and innovation to growth in the value of their shares, in a progressive dividend 22.6* 58 20 21.5* 20 58 20.1 58.3 nurture our Power Brands to above industry and company policy, and continuing share buy backs. 19.3 18.3 56 average growth rates. Our innovation rate at almost 40% of 15 56.7 …in the long-term 15 56 net revenue from products launched in the prior three years 54.9 54 10 54.8 strengthens the positions of our Power Brands within their We are also driving the long-term value of the business 10 54 categories, continually enhancing their consumer appeal. These for shareholders by making our business more sustainable, 53.3 52 innovations are then supported with a marketing investment through building our reputation as a responsible company, 5 0 5 52 that is amongst the highest in our industry – with our media and through taking actions to improve upon the social and 50 environmental impact of our business. 0 50 investment alone running at 12.4% of net revenues. 03 04 05 06 07 03 04 05 06 07 Due to the historical way our business has been built over the Reckitt Benckiser now consistently scores at the head *adjusted to exclude the impact of exceptional items years, through mergers and acquisitions, our Power Brands of industry on external measures of sustainability.
Recommended publications
  • Acquisition Agreement for Paras Pharmaceuticals -- Current
    Dealdoc Acquisition agreement for Paras Pharmaceuticals Paras Pharmaceuticals Reckitt Benckiser Dec 13 2010 © 2009-2021, Wildwood Ventures Ltd. All rights reserved. Acquisition agreement for Paras Pharmaceuticals Paras Pharmaceuticals Companies: Reckitt Benckiser Announcement date: Dec 13 2010 Deal value, US$m: 730.0 : acquisition value • Details • Financials • Termsheet • Press Release • Filing Data • Contract Details Announcement date: Dec 13 2010 Pharmaceutical Industry sectors: Consumer health Financials Deal value, US$m: 730.0 : acquisition value Termsheet 13 December 2010 Reckitt Benckiser has agreed to buy Paras forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million). RB will finance the transaction from existing facilities. Press Release RB Buys India’s Paras Pharmaceuticals Ltd 13 December 2010 Reckitt Benckiser Group plc (RB) today announces that it has agreed to buy Paras Pharmaceuticals Limited (Paras) forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million) from the current shareholders, including the Patel family and Actis, the emerging markets private equity investor. RB will finance the transaction from existing facilities. Paras is a privately-owned Indian company with a portfolio of leading Indian over the counter Health and Personal Care brands including: Moov, the No 2 topical analgesic pain ointment, D’Cold, the No 2 cold & flu remedy, Dermicool, the No 2 for prickly heat, Krack, the No 1 medicated skin treatment for cracked heels and Itch Guard and Ring Guard anti fungal creams. In addition, Paras has a personal care business led by Set Wet, a leading hair gel and deodorant brand. In the fiscal year ending March 2010, Paras generated net sales of INR 4,014 million, representing a mid-teens average growth rate over the last four years, and operating EBITDA for the same year of INR 1,083 million (approximately GBP 56 million and GBP 15 million respectively).
    [Show full text]
  • Consumer Superbrands 2019 Top 10 Consumer Superbrands Relevancy
    Consumer Superbrands 2019 Top 10 Consumer Superbrands BRAND CATEGORY LEGO 1 Child Products - Toys and Education Apple 2 Technology - General Gillette 3 Toiletries - Men's Grooming Rolex 4 Watches British Airways 5 Travel - Airlines Coca-Cola 6 Drinks - Non-Alcoholic - Carbonated Soft Drinks Andrex 7 Household - Kitchen Rolls, Toilet Roll and Tissues Mastercard 8 Financial - General Visa 9 Financial - General Dyson 10 Household & Personal Care Appliances Relevancy Index Top 20 BRAND CATEGORY Amazon 1 Retail - Entertainment & Gifts Aldi 2 Retail - Food & Drink Macmillan Cancer Support 3 Charities Netflix 4 Media - TV Google 5 Social, Search & Comparison Sites Lidl 6 Retail - Food & Drink PayPal 7 Financial - General LEGO 8 Child Products - Toys and Education Samsung 9 Technology - General YouTube 10 Social, Search & Comparison Sites Visa 11 Financial - General Heathrow 12 Travel - Airports Purplebricks 13 Real Estate Cancer Research UK 14 Charities Oral-B 15 Toiletries - Oral Care Apple 16 Technology - General Dyson 17 Household & Personal Care Appliances TripAdvisor 18 Travel - Agents & Tour Operators Nike 19 Sportswear & Equipment Disney 20 Child Products - Toys and Education continues... Consumer Superbrands 2019 Category Winners CATEGORY BRAND Automotive - Products Michelin Automotive - Services AA Automotive - Vehicle Manufacturer Mercedes-Benz Charities Cancer Research UK Child Products - Buggies, Seats and Cots Mamas & Papas Child Products - General JOHNSON'S Child Products - Toys and Education LEGO Drinks - Alcoholic - Beer, Ale
    [Show full text]
  • Reckitt Partners with the Cambridge Centre for Risk Studies As It Advances Its Commitments to Carbon Neutrality
    Reckitt partners with the Cambridge Centre for Risk Studies as it advances its commitments to carbon neutrality 9 June 2021 – Reckitt today announces its strategic partnership with the Cambridge Centre for Risk Studies (CCRS) as it progresses its sustainability ambitions. The partnership advances Reckitt’s ongoing commitment to deliver on the Paris Accord and its ambition for carbon neutrality by 2040 while delivering growth and long-term shareholder value. Its strategy for managing climate change includes action across the entire footprint of its organisation. The CCRS is working with Reckitt to support its climate change activity with analytics, including: • A detailed assessment of leading climate science to test and inform activity within changing patterns of extreme weather, and different scenarios of transition risks including regulatory change and consumer sentiment trends. • Strengthening Reckitt’s financial quantification of these impacts, by mapping Reckitt’s global business activities and the potential consequences of future changes. • Analysis of potential ways to evolve the business to achieve its goals for the Paris Accord and net-zero ambitions. Reckitt is the official Hygiene Partner for COP26, and is playing its part in tackling climate change by setting science-based targets to reach net zero emissions. In June 2020, Reckitt committed to accelerate the delivery of the Paris Climate Change Agreement and RE100, with the goal of achieving 100% renewable electricity across its operations by 2030 as part of an ambition to be carbon neutral by 2040. David Croft, Global Director of Sustainability, Reckitt, said: “We selected Cambridge because of its experienced, comprehensive and science-based approach to assessing and addressing climate-related risks, opportunities and metrics.
    [Show full text]
  • Reckitt Benckiser 0000 Paracetamol Posology Update 2019-04
    Reckitt Benckiser 0000 Paracetamol Posology Update 2019-04 Package Leaflet: Information for the User • Sodium (129.0mg per sachet), main component of cooking/table salt. This is equivalent to 6.45% of RB Artwork and Lemsip Max Honey & Ginger Flavour Powder for Oral Solution the recommended maximum daily dietary intake of sodium for an adult. Print Specification (paracetamol and phenylephrine hydrochloride) 3. How to take this medicine Trident Reference No: RB251338 Please read this leaflet carefully before you take this medicine. If you are not sure of anything ask your To be made into a hot drink. Dissolve one sachet in a mug of hot but not boiling water. Stir until dissolved. If preferred sweeten to taste with sugar, honey or your usual sweetener. ZEN Ref: TR1197000 pharmacist or doctor. 250 It is important to drink plenty of fluids when suffering from colds and flu. Action: D 1. What this medicine is and what it is used for? Adults, the elderly and children 16 years and over: Brand: Lemsip Lemsip Max Honey & Ginger Flavour Powder for Oral Solution contains a combination of ingredients One sachet every 4-6 hours as required. Do not take more than 4 sachets in 24 hours. Category: Max which are effective in relieving the symptoms associated with colds and flu, including relief of aches and Segment Group: Cold & Flu pains, sore throats, headache, nasal congestion and lowering of temperature. Do not give to children under 16 years. Segment: Honey & Ginger Paracetamol is a well-known painkiller (analgesic). It is effective against aches and pains, including a headache, If the symptoms of your cold or flu persist for more than three days, or worsen, consult your pharmacist.
    [Show full text]
  • RB Partners with Veolia to Drive a Circular Plastics Economy
    RB partners with Veolia to drive a circular plastics economy Reckitt Benckiser (RB) and Veolia have today announced their partnership to drive the shift to a circular plastics economy. The partnership with Veolia is another step RB is taking to fulfil its pledge to make 100 percent of its plastic packaging recyclable and to contain at least 25 percent recycled content by 2025. Veolia and RB started working together two years ago to work on increasing the use of postconsumer recycled plastic in RB’s packaging. The first offering from the partnership is the new packaging for Finish Quantum. The packaging now contains 30% recycled plastic and is proudly grey in colour because RB has decided not to add masking pigments or additives to the packaging. The companies will continue their collaboration on designing for recyclability and the maximization of post-consumer recycled content. To accelerate the circular plastics economy, a team of 20 experts from RB and Veolia are also working to develop enhanced collection systems, driving behaviour change to aid consumer sorting habits and improving recycling from households. “The partnership between Veolia and RB Hygiene Home brings together our complementary capabilities to drive ​ a positive contribution to the circular economy. We have just started the journey by increasing recycled content and improving recyclability and are excited about the wider opportunities across our value chains”, says Fabrice ​ Beaulieu, EVP Marketing, R&D and Sustainability for RB Hygiene Home. “We are delighted to be collaborating with RB on this ongoing strategy to reduce their environmental footprint. ​ We are working hand-in-hand with RB to develop packaging with greater recycled content and improved recyclability for the RB group’s consumers,” says Antoine Frérot, Chairman and CEO of Veolia.
    [Show full text]
  • Product & Price# of Barcodes
    Product & Price# of Barcodes <span class="hilite">Cleaning</span> Air Wick Freshmatic Ultra1 Starter Kit (2 gadgets + 2 refills) - $12.99 Air Wick Freshmatic Ultra4 Refill (4 pack/6.17 oz) - $13.99 Air Wick Scented Oils1 (1 warmer + 7 refills) - $11.99 Air Wick Scented Oils1 Refill (8 pack) - $12.99 Air Wick Candles (twin2 pack) - $9.99 Clorox Foaming Bathroom3 Cleaner (3 pack/30 oz) - $8.49 Clorox Toilet Wand (361 ct refill with bonus wand) - $16.49 Clorox Automatic Toilet1 Bowl Cleaner (6 ct/3.5 oz) - $10.79 Clorox Disinfecting Wipes1 (5 pack/78 ct) - $14.99 Clorox Green Works Natural2 Cleaner (twin pack) - $4.99 Clorox Oxi Magic (7.81 lbs) - $9.99 Clorox Clean Up (1802 oz + 32 oz trigger) - $10.49 Clorox Pool & Spa Shock1 Plus, 12 pk./1 lb. $34.99 Clorox Pool & Spa Algaecide and Clarifier, 2 pk./1 gal. $14.99 Clorox Pump 'n Clean (2 pumps + 2 refills/18 oz) - $9.99 Clorox Bleach (2/182 2oz bottles) - $5.99 Damp Rid Moisture 46 Pack Hanging - $9.99 DampRid Buckets (6 pack)1 - $9.99 Fabuloso All Purpose 3Cleaner (169 oz) - $7.99 Febreze Air Effects (32 pack/9.7 oz) - $6.99 Febreze Air Effects Heavy1 Duty Crisp Clean Air Freshener (twin pack/19.4 oz) - $5.99 Febreze Set and Refresh2 (2 ct) - $7.99 Febreze Fabric 2 ct. 541 oz. - $7.99 Febreze Car Vent Clips3 (4 ct) $8.99 Febreze Unstopables2 (3 pack/8.8 oz) 8.99 Formula 409 (180 oz 1+ 32 oz) - $11.99 Glade PlugIns (2 warmers1 + 6 refills) - $11.49 Glade PlugIns (8 pack2 refill) - $12.99 Kaboom (twin pack/403 oz) - $8.79 Liquid Plumbr Foam Pipesnake2 (3 pack/17 oz) - $8.99 Liquid Plumbr ProStrength3 (twin pack/80 oz) - $9.99 Lysol Neutra Air (3 pack/164 oz) - $9.99 Lysol Neutra Air Sanitizing4 Spray, 3 pk./16 oz.
    [Show full text]
  • Rb-Annual-Report-2012.Pdf
    Reckitt Benckiser Group plc Reckitt Benckiser Group Healthier Happier Annual Report and Financial Statements 2012 Stronger Reckitt Benckiser Group plc Annual Report and Financial Statements 2012 Contents 1 Chairman’s Statement 2 Chief Executive’s Statement 10 Business Review 2012 18 Board of Directors and Executive Committee 19 Report of the Directors 22 Chairman’s Statement on Corporate Governance 24 Corporate Governance Report 30 Statement of Directors’ Responsibilities 31 Directors’ Remuneration Report 38 Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 39 Group income statement 39 Group statement of comprehensive income 40 Group balance sheet 41 Group statement of changes in equity 42 Group cash flow statement 43 Notes to the financial statements 75 Five-year summary 76 Parent Company – Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 77 Parent Company balance sheet 78 Notes to the Parent Company financial statements 84 Shareholder information Chairman’s Statement largest consumer health care category in The Board conducted its regular reviews the world with the acquisition of Schiff of the Company’s brands, geographic area Nutrition International, Inc. (Schiff) and and functional performance together with its leading US brands in the vitamins, detailed reviews of its human resources. minerals and supplements market. There The Board also completed its annual were also a few disposals of non core assessment of corporate governance assets. Net debt at the end of 2012, after including Board performance, corporate paying for dividends, net acquisitions and responsibility, and reputational and organisation restructuring, stood at business risk. £2,426m (2011: £1,795m). AGM Resolutions Your Board proposes an increase in the final The resolutions, which will be voted dividend of +11%, taking it to 78p per upon at our AGM of 2 May 2013 are share, and bringing the total dividend for fully explained in the Notice of Meeting.
    [Show full text]
  • RB Acquires Queen V
    RB Acquires Queen V An insurgent consumer loved brand in $7Bln+ female intimate hygiene category, re- enforcing commitment to Sexual Wellbeing growth, de-stigmatization and development. London, January 20, 2021 – RB today announces that it has acquired Queen V, a feminine wellness brand established in the US, focused on vaginal health. Founded in 2018 in California, Queen V takes a unique and inclusive approach to vaginal health with its commitment to make feminine wellness more accessible and empower women to take control of their bodies. The acquisition of the Queen V brand is demonstrative of RB’s commitment to innovative, purpose-driven brands that consumers love and is in line with the strategy to play in new spaces and adjacencies. Queen V will be part of RB’s Health Global Business Unit, alongside leading sexual wellbeing brands, KY and Durex. “Queen V is a fantastic purpose-driven brand with products that appeal to the needs of our diverse and evolving customer base. This innovative brand has the potential to enhance wellness and make a positive difference to many consumers’ daily lives. Working together with the Queen V team, we are committed to the shared mission of de-stigmatization, focusing on women’s needs and vagina-positivity” said Olga Osminkina-Jones, Global Senior Vice President of Sexual Wellbeing at RB. For further information, please contact: [email protected] / [email protected] About RB RB* is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.
    [Show full text]
  • Elegant Napkins 500Ct 12Pk $22.49 Elegant Tissues 230Ct 24Pk $20.49
    1 2 Elegant Napkins Elegant Tissues 500ct 12pk $22.49 230ct 24pk $20.49 For questions regarding prices on Terms and Conditions large quantity orders, please email $1,000 minimum order for free delivery within the 5 boroughs of NY, or fax us a list of the items you are NJ & PA. interested in along with quantities. Tailgate delivery only. We can order specialty items Freight charge of $75 for orders under minimum. direct from all major Call for rates outside the NJ/NY area. manufacturers. Easy ordering: All sales are COD cash unless arranged in advanced. Phone, Fax, Online or contact your We ship paper products or specials only equal amount of the other sales rep. We appreciate your products. business and look forward to Prices and availability are subject to change. providing you with quality products Unit price is listed for reference only. and excellent customer service. Prices are by the case ONLY. We are not responsible for any typographical errors. Pictures are a representation of product and may not be exactly the same. We reserve the right to limit quantities ordered. 1 2 3 Member's Mark Long Member's Mark Member's Mark Long Pepsi-Cola Can 4 Grain White Rice - 25lb Parboiled Rice Long Grain White Rice - 50lb 12oz/36pk Grain - 25lb Clorox Toilet Bowl Cleaner All Soft Scrub Cleaner All kinds- kinds 24oz/9pk 24oz/12pk $22.49 $21.49 $11.59 $13.49 $19.49 $0.35 $1.79 $2.50 $11.99 $11.59 $13.99 $13.49 $19.99 $19.49 $12.99 $12.59 Pledge Multi-Surface Spray All Gain Ultra Powder Detergent All Pepsi-Cola Bottles Coca Cola Cans
    [Show full text]
  • RB Full Year 2017 Results Presentation
    RB Full Year 2017 Results Presentation 191919 ththth February 2018 Disclaimer Cautionary note concerning forwardforward----lookinglooking statements This presentation contains statements with respect to the financial condition, results of operations and business of RB (the “Group”) and certain of the plans and objectives of the Group that are forward-looking statements. Words such as ‘‘intends’, ‘targets’, or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including targets for net revenue, operating margin and cost efficiency, are forward-looking statements. Such statements are not historical facts, nor are they guarantees of future performance. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including many factors outside the Group’s control. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: the general economic, business, political and social conditions in the key markets in which the Group operates; the ability of the Group to manage regulatory, tax and legal matters, including changes thereto; the reliability of the Group’s technological infrastructure or that of third parties on which the Group relies; interruptions in the Group’s supply chain and disruptions to its production facilities; the reputation of the Group’s global brands; and the recruitment and retention of key management.
    [Show full text]
  • Durex in India: the Category Normalisation Challenge
    IIMC-CRC-2015-09 IIMC CASE RESEARCH CENTRE (IIMCCRC) PRASHANT MISHRA, TINU JAIN MARCH 2014 DUREX IN INDIA: THE CATEGORY NORMALISATION CHALLENGE THE ORIGIN Reckitt Benckiser, a British multinational consumer goods company, has brands like Dettol (the world's largest-selling antiseptic), Strepsils (the world's largest-selling sore throat medicine), Veet (the world's largest-selling depilatory brand), Air Wick (the world's second- largest-selling air freshener), Calgon, Clearasil, Cillit Bang, Durex, Lysol, and Vanish in its portfolio among many others. The company entered into the contraceptive market acquiring Durex brand globally and had started to run that business since Nov’12. Durex has been making highest quality condoms for nearly 80 years. With over 30% of the global branded condom market, it is the number 1 condom brand in the world. However despite dominant market position globally, the brand has the challenge to change the perception of Indian consumers and channel partners regarding sexual well-being (male contraceptive) to normalise the category and drive growth. The current market share of Durex is around 4%1 in India, a market which is underdeveloped compared to other markets regarding the category size and growth. The brand team acknowledges that there is a lot to be done to make the brand a formidable player in the sexual well-being (male contraceptive) category. A recent study commissioned by the Durex brand marketing team has thrown up some interesting facts about the category dynamics and challenges in marketing condom in India. While pondering over the results, the team was clear about one thing, that to play 1 Source: Brand Marketing Team Survey This case was written by Professor Prashant Mishra and Tinu Jain at the Indian Institute of Management Calcutta.
    [Show full text]
  • Project Flower
    FOR IMMEDIATE RELEASE Reckitt Benckiser Group plc Recommended acquisition of Mead Johnson Nutrition Company by Reckitt Benckiser Group plc Expected completion date of acquisition 12th June 2017, Slough UK, Reckitt Benckiser Group plc (“RB”) is pleased to announce that the final regulatory approval has now been received in connection with the recommended acquisition of Mead Johnson Nutrition Company by RB. Completion of this acquisition is expected to occur on June 15th 2017. About RB: RB* is the world’s leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide. Led by a purpose of providing innovative solutions for healthier lives and happier homes, RB is amongst the top 10 companies listed on the London Stock Exchange. It is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional focus on innovation. RB’s Health, Hygiene and Home portfolio is led by its global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French’s. Powerbrands represent 80% of RB’s net revenue. RB is redefining the world of consumer health and hygiene. Its people and unique culture are at the heart of its success. It has a drive for achievement and a passion to outperform wherever it focuses, including sustainability where it is targeting a 1/3 reduction in water impact, a 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products.
    [Show full text]